Table 2.

(A) Effects of up to 4 months of STG exposure on serum glucose, bilirubin and protein profiles of Fisher 344 male and female rats

Protein (units)	Female (2 months)			Male (2 months)			Female (4 months)			Male (4 months)
	Con	1x	7x	Con	1x	7x	Con	1x	7x	Con	1x	7x
Glucose (mg/dL)	233 ± 10.0	237 ± 4.00	282 ± 33.00	210 ± 1.50	245 ± 4.00	318 ± 3.80	166 ± 4.00	167 ± 10.0	168 ± 8.00	207 ± 4.50	203 ± 9.00	156 ± 11.00
Tot. Protein (g/dL)	7.50 ± 0.0	7.10 ± 0.10	6.80 ± 0.20	7.70 ± 1.00	6.90 ± 1.00	6.50 ± 0.06	7.30 ± 0.17	7.60 ± 0.21	7.60 ± 0.17	8.20 ± 0.06	8.90 ± 0.06	8.70 ± 0.20
Albumin (A) (g/dL)	3.9 ± 0.03	3.6 ± 0.06	3.50 ± 0.10	3.80 ± 0.03	3.40 ± 0.03	3.40 ± 0.03	3.80 ± 0.18	4.10 ± 0.06	4.00 ± 0.14	3.57 ± 0.14	4.00 ± 0.12	3.96 ± 0.12
Globulin (G) (g/dL)	3.60 ± 0.03	3.40 ± 0.03	3.30 ± 0.17	3.87 ± 1.3	3.40 ± 0.09	3.06 ± 0.09	3.46 ± 0.03	3.50 ± 0.20	3.60 ± 0.17	4.63 ± 0.12	4.90 ± 0.6	4.77 ± 0.09
A/G Ratio	1.10	1.06	1.06	1.03	0.97	1.13	1.13	1.20	1.13	0.80	0.83	0.83
Alkaline phosphatase (Units/L)	183 ± 3.48	178 ± 0.88	157 ± 9.60	184 ± 1.66	191 ± 3.40	144 ± 0.90	140 ± 10.0	138 ± 1.30	120 ± 7.50	119 ± 3.93	121 ± 2.30	129 ± 3.70
C-Reactive protein (mg/dL)	0.070 ± 0.03	0.100 ± 0.0	0.133 ± 0.03	0.130 ± 0.03	0.670 ± 0.03	0.070 ± 0.03	0.170 ± 0.06	0.100 ± 0.0	0.100 ± 0.06	0.100 ± 0.00	0.160 ± 0.03	0.060 ± 0.03
Homocysteine (µMol/L	17.2 ± 1.40	15.8 ± 0.802	15.70 ± 2.02	20.20 ± 1.40	19.10 ± 3.00	17.60 ± 1.30	15.90 ± 0.50	14.90 ± 0.97	13.60 ± 1.23	16.40 ± 1.70	17.70 ± 1.18	15.70 ± 0.48
Bilirubin (mg/dL)	0.77 ± 0.03	0.57 ± 0.03	0.40 ± 0.06	0.50 ± 0.00	0.60 ± 0.00	0.33 ± 0.03	0.67 ± 0.08	0.63 ± 0.06	0.56 ± 0.12	0.76 ± 0.09	1.16 ± 0.14	0.83 ± 0.09

Values represent mean ± SE, n = 3; *p ≤ 0.05 Control vs. treated if indicated; Human reference range: Glucose: 70–105; Tot. protein: 6.0–8.0; Albumin: 3.5–5.2; Globulin: 1.5–3.0; A/G ratio: 1.5–2.5; Alk. Phos.: 0–138; C-Reactive protein: 0–3; Homocysteine: 0–12; Bilirubin: 0.2–1.0.